ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 86 filers reported holding ANTARES PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $4,820,000 | -81.6% | 3,983,440 | -74.2% | 0.20% | -80.8% |
| Q3 2015 | $26,267,000 | -31.3% | 15,451,124 | -16.0% | 1.02% | -20.3% |
| Q2 2015 | $38,251,000 | +16.9% | 18,389,789 | +52.3% | 1.27% | +20.2% |
| Q1 2015 | $32,732,000 | +57.2% | 12,078,318 | +49.0% | 1.06% | +41.7% |
| Q4 2014 | $20,828,000 | +45.5% | 8,104,318 | +3.6% | 0.75% | +43.3% |
| Q3 2014 | $14,317,000 | -44.2% | 7,823,618 | -18.5% | 0.52% | -49.4% |
| Q2 2014 | $25,642,000 | -22.8% | 9,603,703 | +1.2% | 1.03% | -24.0% |
| Q1 2014 | $33,210,000 | -26.8% | 9,488,461 | -6.4% | 1.36% | -42.3% |
| Q4 2013 | $45,341,000 | +29.1% | 10,141,174 | +17.2% | 2.35% | +43.8% |
| Q3 2013 | $35,132,000 | -10.2% | 8,653,119 | -7.9% | 1.63% | -11.3% |
| Q2 2013 | $39,104,000 | – | 9,400,000 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |